SCHOFIELD, Wis., Oct. 13, 2009 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic(TM), announced today that it has recently secured funding in excess of $325,000 which has allowed the Company to further efforts to reach its goals and objectives.
